DaVita Market Cap 2010-2024 | DVA

DaVita market cap history and chart from 2010 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. DaVita market cap as of January 10, 2025 is $12.29B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.285B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.257B 0.00
Quest Diagnostics (DGX) United States $16.849B 17.08
Encompass Health (EHC) United States $9.254B 21.82
Chemed (CHE) United States $7.946B 24.42
Elanco Animal Health (ELAN) United States $5.957B 14.18
RadNet (RDNT) United States $5.193B 115.00
Option Care Health (OPCH) United States $3.863B 18.31
Amedisys (AMED) United States $2.977B 21.19
LifeStance Health (LFST) United States $2.889B 0.00
Addus HomeCare (ADUS) United States $2.253B 26.44
Astrana Health (ASTH) United States $1.811B 24.77
U.S Physical Therapy (USPH) United States $1.327B 34.87
Pennant (PNTG) United States $0.909B 36.75
Aveanna Healthcare Holdings (AVAH) United States $0.871B 0.00
Atai Life Sciences (ATAI) Germany $0.268B 0.00
Bioqual (BIOQ) United States $0.058B 0.00
Daxor (DXR) United States $0.037B 0.00
Ontrak (OTRK) United States $0.008B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00
Psychemedics (PMD) United States $0.000B 0.00